A prognostic model for development of significant liver fibrosis in HIV-hepatitis C co-infectionNasheed Moqueet, Cynthia Kanagaratham, M. John Gill et al.|PLoS ONE|2017Cited by 8
A tale of two countries: all‐cause mortality among people living with <scp>HIV</scp> and receiving combination antiretroviral therapy in the <scp>UK</scp> and CanadaSophie Patterson, Caroline Sabin, Angela Cescon et al.|HIV Medicine|2017Cited by 3